
---
title: '海辰药业：注射用替加环素通过仿制药一致性评价'
categories: 
 - 金融
 - 证券时报网
 - 快讯
headimg: 'https://picsum.photos/400/300?random=4655'
author: 证券时报网
comments: false
date: Wed, 09 Feb 2022 18:34:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=4655'
---

<div>   
<p>证券时报e公司讯，<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SZ300584" style="color: #2f67d1;text-decoration: none;" code="300584" target="_blank">海辰药业</a>(300584)2月9日晚间公告，公司产品注射用替加环素通过仿制药一致性评价。</p>

                  
</div>
            